鲁抗医药 (600789.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(鲁抗医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 30.0026.0018.0025.0022.0025.0019.0023.00
 单季度销售净利率(%) 4.004.006.003.003.002.002.003.00
 单季度净资产收益率ROE(%) 2.002.002.001.001.001.001.001.00
 单季度总资产净利率ROA(%) 1.001.001.001.001.00--1.00
单季度财务摘要:
 单季度营业总收入(元) 1,414,856,593.001,545,695,649.001,516,356,290.001,669,812,908.001,568,590,255.001,377,001,886.001,351,268,689.001,324,581,074.00
 单季度营业总成本(元) 1,335,713,610.001,504,225,292.001,452,504,745.001,615,220,491.001,490,747,907.001,356,775,310.001,327,690,225.001,280,155,509.00
 单季度营业收入(元) 1,414,856,593.001,545,695,649.001,516,356,290.001,669,812,908.001,568,590,255.001,377,001,886.001,351,268,689.001,324,581,074.00
 单季度营业利润(元) 50,953,082.0072,064,316.0094,022,717.0055,093,337.0048,191,887.0025,832,969.0024,689,003.0050,059,839.00
 单季度利润总额(元) 51,136,696.0072,388,885.0094,265,586.0055,184,003.0048,227,859.0026,703,158.0024,982,251.0050,182,093.00
 单季度净利润(元) 56,841,047.0064,219,777.0088,311,685.0047,414,780.0048,402,458.0025,404,800.0023,602,810.0045,704,913.00
 单季度归属母公司股东的净利润(元) 53,620,335.0061,173,140.0085,689,733.0045,688,589.0046,412,724.0024,553,874.0022,457,678.0044,588,853.00
 单季度经营活动产生的现金流量(元) 143,430,531.0075,253,636.00254,432,205.00130,889,329.00163,603,652.00262,832,925.00-50,518,577.0068,459,009.00
 单季度投资活动产生的现金流量(元) -83,981,313.00-94,418,741.00-136,389,959.00-54,985,097.00-164,193,771.00-160,630,184.00-71,410,878.00-47,770,399.00
 单季度筹资活动产生的现金流量(元) 53,303,582.00-67,951,591.0058,721,546.00-137,996,820.00-11,247,549.00-43,974,163.0058,931,978.00-9,018,694.00
 单季度现金及现金等价物净增加(元) 114,236,087.00-87,255,736.00179,750,873.00-63,723,896.00-7,417,015.0059,216,681.00-61,165,436.0010,885,975.00

前瞻产业研究院